Verve Therapeutics is a clinical-stage company developing genetic medicines for cardiovascular disease, with its lead program ...

B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular ...

NEW YORK — (AP) — U.S. stock indexes are drifting lower on Tuesday, while oil prices rise again.

Stocks declined Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and as hopes for a quick ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...